ConductScience.org, home

Paper30628811

Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.

Sakloth F and 5 others. Exp Clin Psychopharmacol, 2019. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. Papers, record 30628811. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30628811

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.
PubMed
Journal
Exp Clin Psychopharmacol
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.99
iCite
Revised in PubMed
2020-06-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sakloth FFarhana
2Leggett EElizabeth
3Moerke MJMegan J
4Townsend EAE Andrew
5Banks MLMatthew L
6Negus SSS Stevens

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Analgesics, OpioidMajor topic
HallucinogensMajor topic
Self StimulationMajor topic
Serotonin 5-HT2 Receptor AgonistsMajor topic
Animals
Dose-Response Relationship, Drug
Male
Medial Forebrain Bundle
Rats
Rats, Sprague-Dawley
Receptor, Serotonin, 5-HT2A
Receptors, Opioid, kappa

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DA033930NIDA NIH HHSUnited StatesR01DA033930PubMed and NIHNIH RePORTER
T32 DA007027NIDA NIH HHSUnited StatesT32DA007027PubMed and NIHNIH RePORTER
National Institutes of Health; National Institute on Drug AbusePubMedPubMed

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,064,726Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.J Pharmacol Exp Ther1976https://conductscience.org/library/papers/1064726PubMed
212,213,075Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).J Med Chem2002https://conductscience.org/library/papers/12213075PubMed
313,717,955Cross tolerance between LSD and psilocybin.Psychopharmacologia1961https://conductscience.org/library/papers/13717955PubMed
414,119,492PHARMACOLOGICAL PATTERNS IN SUBCORTICAL REINFORCEMENT BEHAVIOR.Int J Neuropharmacol1963https://conductscience.org/library/papers/14119492PubMed
514,161,141TOLERANCE TO BEHAVIORAL EFFECTS OF LSD-25 IN RAT.J Pharmacol Exp Ther1964https://conductscience.org/library/papers/14161141PubMed
614,727,002Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.Psychopharmacology (Berl)2004https://conductscience.org/library/papers/14727002PubMed
715,019,419LSD, 5-HT (serotonin), and the evolution of a behavioral assay.Neurosci Biobehav Rev2004https://conductscience.org/library/papers/15019419PubMed
815,096,915Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.Behav Pharmacol2004https://conductscience.org/library/papers/15096915PubMed
917,196,053Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.J Clin Psychiatry2006https://conductscience.org/library/papers/17196053PubMed
1017,695,343G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.Behav Res Methods2007https://conductscience.org/library/papers/17695343PubMed
1117,977,517The behavioral pharmacology of hallucinogens.Biochem Pharmacol2008https://conductscience.org/library/papers/17977517PubMed
1218,007,634Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation.Nat Protoc2007https://conductscience.org/library/papers/18007634PubMed
1319,782,055Dynorphin, stress, and depression.Brain Res2010https://conductscience.org/library/papers/19782055PubMed
1420,101,391Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.Psychopharmacology (Berl)2010https://conductscience.org/library/papers/20101391PubMed
1520,493,209Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats.Pharmacol Biochem Behav2010https://conductscience.org/library/papers/20493209PubMed
1620,577,718Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine.Psychopharmacology (Berl)2011https://conductscience.org/library/papers/20577718PubMed
1720,819,978Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.Arch Gen Psychiatry2011https://conductscience.org/library/papers/20819978PubMed
1822,406,913Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials.J Psychopharmacol2012https://conductscience.org/library/papers/22406913PubMed
1922,978,626Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.Br J Pharmacol2013https://conductscience.org/library/papers/22978626PubMed
2023,851,484Rate-dependent effects of monoamine releasers on intracranial self-stimulation in rats: implications for abuse liability assessment.Behav Pharmacol2013https://conductscience.org/library/papers/23851484PubMed

See all 55 references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
42,076,014Electrocorticographic Changes and Neuronal Maturation in the Antidepressant-like and Anxiolytic Effects of Micro- or Macrodosing of Psilocybe cubensis Mushroom in Mice.Molecules2026https://conductscience.org/library/papers/42076014PubMed
41,751,376Opioid Receptors in Psychedelia: Indirect Serotonergic Modulation of Direct KOR Activation by Salvinorin A.Biomedicines2026https://conductscience.org/library/papers/41751376PubMed
41,266,307Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid reward.Nat Commun2025https://conductscience.org/library/papers/41266307PubMed
40,047,011Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents.Psychedelic Med (New Rochelle)2023https://conductscience.org/library/papers/40047011PubMed
39,467,003Preclinical models for evaluating psychedelics in the treatment of major depressive disorder.Br J Pharmacol2026https://conductscience.org/library/papers/39467003PubMed
39,228,432Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets.Subst Abuse Rehabil2024https://conductscience.org/library/papers/39228432PubMed
38,203,411Molecular and Medical Aspects of Psychedelics.Int J Mol Sci2023https://conductscience.org/library/papers/38203411PubMed
37,999,867The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.CNS Drugs2023https://conductscience.org/library/papers/37999867PubMed
37,940,583Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.J Neurosci2023https://conductscience.org/library/papers/37940583PubMed
37,886,350Role of mu opioid receptor (MOR) agonist efficacy as a determinant of opioid antinociception in a novel assay of pain-depressed behavior in female and male mice.Front Pain Res (Lausanne)2023https://conductscience.org/library/papers/37886350PubMed
37,886,127μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges.Front Pharmacol2023https://conductscience.org/library/papers/37886127PubMed
37,759,040Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics.Mol Psychiatry2023https://conductscience.org/library/papers/37759040PubMed
36,272,734Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys.J Pharmacol Exp Ther2023https://conductscience.org/library/papers/36272734PubMed
36,241,352
Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).
BMJ Open2022https://conductscience.org/library/papers/36241352PubMed
36,097,251A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.CNS Drugs2022https://conductscience.org/library/papers/36097251PubMed
35,695,174Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice.J Psychopharmacol2022https://conductscience.org/library/papers/35695174PubMed
35,233,648Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.Psychopharmacology (Berl)2022https://conductscience.org/library/papers/35233648PubMed
34,296,204A Strategy to Prioritize Emerging Drugs of Abuse for Analysis: Abuse Liability Testing Using Intracranial Self-Stimulation (ICSS) in Rats and Validation with α-Pyrrolidinohexanophenone (α-PHP).Emerg Trends Drugs Addict Health2021https://conductscience.org/library/papers/34296204PubMed
32,922,736The therapeutic potential of microdosing psychedelics in depression.Ther Adv Psychopharmacol2020https://conductscience.org/library/papers/32922736PubMed
32,458,577Effects of 5-HT2A receptor stimulation on economic demand for fentanyl after intermittent and continuous access self-administration in male rats.Addict Biol2021https://conductscience.org/library/papers/32458577PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HTR1A3,350PubTator's text mininghttps://conductscience.org/library/genes/3350NCBI Gene
HTR2A3,356PubTator's text mininghttps://conductscience.org/library/genes/3356NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30628811

GET https://conductscience.org/api/papers/v1/30628811/references?page=2